US markets rise as Democrats sweep midterm elections

US equities opened higher after Democrats took control of both chambers in the midterms and President Trump said he would accept the results: the Dow rose 1.8%, the S&P 500 1.1% and the Nasdaq 1.0%. Walmart and Target gained 1.3% and 3.3%, respectively, while UnitedHealthcare fell 2.9% and CVS Health dropped 12%; Oracle and Nvidia also opened lower amid concerns about future AI legislation. Brent fell $3.20 (3.09%) to $100.40 a barrel and WTI lost $3.01 (3.13%) to $93.08, with investors also monitoring potential developments in the Iran and Russia-Ukraine wars.

Analysis

Treat the opening rally as a sentiment reset, not evidence of a durable earnings upgrade. Over days, tariff-sensitive retailers could benefit if policy actually lowers import costs, but tariff relief may be delayed, partly passed through to consumers, or offset by supplier pricing; executive authority also means congressional control alone does not establish the policy path. Over 1–3 months, watch for concrete tariff proposals and retailer gross-margin commentary before extrapolating the moves in WMT and TGT.

The AI read-through is more nuanced than a blanket sector penalty. Legislative friction could delay some projects, but an estimate that 10% of data centers will not proceed is an analyst claim, not verified cancellations. Delays would affect equipment orders and deployment timing for NVDA and ORCL, while potentially shifting spend toward incumbent cloud platforms such as GOOG; Alphabet is not insulated if customers defer capacity or regulation raises compliance costs. Permitting, power availability, and project financing may matter as much as federal legislation over 6–18 months.

The CVS/Cigna divergence argues against treating the session as a clean sector signal. CVS’s sharp decline warrants checking company-specific exposure and guidance before assigning an election-policy cause; a further deterioration in its operating outlook would falsify a simple mean-reversion thesis. Oil’s retreat is vulnerable to reversal if Iran/Russia diplomacy fails or supply risks reprice. The broad index gains may fade if policy uncertainty, rates, or earnings expectations worsen.

Key Decisions for Investors

• Do not chase the opening index rally. Reassess after policy details and subsequent sessions; a reversal of the initial gains alongside higher volatility would indicate relief-flow rather than durable repricing.
• Keep WMT and TGT on a conditional tariff-relief watchlist, not as an immediate policy trade. Add exposure only if credible tariff changes emerge and management commentary supports margin benefit; trim the thesis if costs remain sticky or consumer pricing absorbs the relief.
• For AI, avoid treating the cited data-center cancellation estimate as fact. Track project cancellations, hyperscaler capex guidance, permitting/power constraints, and order commentary; persistent capex cuts would strengthen a cautious view on NVDA and ORCL, while continued spending would undermine it.
• Do not buy the CVS drawdown solely on the election narrative or infer a broad insurer short from one session. Verify the driver and subsequent guidance; a worsening operating outlook or policy-specific adverse development would argue against a rebound, while stabilization without estimate cuts would weaken the bearish case.
• Avoid a directional oil trade on this headline alone. Any short exposure needs confirmation from sustained crude weakness and evidence that geopolitical risk is receding; renewed escalation or a supply disruption is the key reversal risk.